Mark Painter

Mark graduated from The University of St. Thomas in St. Paul, Minnesota with a B.S. in Biology in 2014, and subsequently entered the Graduate Program in Immunology at the University of Michigan. There, he studied how HIV evades the immune response and establishes a persistent infection, completing his PhD in November 2020. He began a postdoctoral research fellowship to study human immunology and vaccination at the University of Pennsylvania in January 2021, where he currently co-leads a team that has published several high-profile studies on the immune response to SARS-CoV-2 vaccination and infection, appearing in journals including Science Immunology, Immunity, Nature Medicine, and Science.